C4 Therapeutics (CCCC) Other Gross PP&E Adjustments (2019 - 2026)

C4 Therapeutics' Other Gross PP&E Adjustments history runs 8 years deep, the most recent figure standing at -$23.5 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 42.49% year-over-year to -$23.5 million; the TTM figure through Mar 2026 stood at -$23.5 million (up 42.49% YoY), while the FY2025 annual figure was -$38.7 million, up 27.62% from the prior year.
• Other Gross PP&E Adjustments was -$23.5 million for Q1 2026 at C4 Therapeutics, up from -$38.7 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of -$23.5 million in Q1 2026 to a low of -$65.6 million in Q1 2022.
• Historically, Other Gross PP&E Adjustments has averaged -$47.9 million across 5 years, with a median of -$50.3 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Other Gross PP&E Adjustments plunged 1735.26% in 2022, then soared 42.49% in 2026.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at -$60.9 million in 2022, then grew by 4.54% to -$58.1 million in 2023, then increased by 8.02% to -$53.5 million in 2024, then grew by 27.62% to -$38.7 million in 2025, then jumped by 39.35% to -$23.5 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$23.5 million (Q1 2026), -$38.7 million (Q4 2025), and -$26.4 million (Q3 2025), per Business Quant data.